INSULIN ASPART for Device therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where INSULIN ASPART was used for Device therapy.
Most Reported Side Effects for INSULIN ASPART
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Blood glucose increased | 4,743 | 21.6% | 28 | 1,236 |
| Hypoglycaemia | 1,647 | 7.5% | 55 | 964 |
| Blood glucose decreased | 1,421 | 6.5% | 6 | 361 |
| Diabetic ketoacidosis | 1,398 | 6.4% | 28 | 1,102 |
| Drug ineffective | 1,243 | 5.7% | 65 | 344 |
| Product quality issue | 1,049 | 4.8% | 2 | 247 |
| Dyspnoea | 746 | 3.4% | 146 | 319 |
| Vomiting | 727 | 3.3% | 226 | 300 |
| Malaise | 706 | 3.2% | 3 | 154 |
| Nausea | 694 | 3.2% | 216 | 251 |
| Diabetes mellitus inadequate control | 668 | 3.0% | 13 | 256 |
| Hyperglycaemia | 646 | 2.9% | 20 | 341 |
| Condition aggravated | 603 | 2.7% | 206 | 292 |
| Dizziness | 579 | 2.6% | 4 | 115 |
| Fall | 555 | 2.5% | 17 | 281 |
Other Indications for INSULIN ASPART
Product used for unknown indication (7,054)
Type 2 diabetes mellitus (5,748)
Type 1 diabetes mellitus (3,913)
Diabetes mellitus (3,380)
Gestational diabetes (305)
Hyperglycaemia (69)
Diabetes mellitus inadequate control (63)
Blood glucose increased (55)
Foetal exposure during pregnancy (55)
Latent autoimmune diabetes in adults (48)